We invest in and incubate private companies with innovative therapeutic products and platforms that address substantial, unmet medical needs in China.

The investment strategy of Pivotal bioVenture Partners China is centered on identifying promising innovative products and technologies and bringing them to serve the growing unmet medical needs in Greater China region by building new ventures. Its investment areas include therapeutics, medical devices and medical services.

The Pivotal China team includes experienced life science investors and entrepreneurs with successful track records of venture building and investing.